Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway

During the COVID-19 pandemic in Norway, the testing criteria and capacity changed numerous times. In this study, we aim to assess consequences of changes in testing criteria for infectious disease surveillance. We plotted the proportion of positive PCR tests and the total number of PCR tests for dif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2024-08, Vol.19 (8), p.e0308978
Hauptverfasser: Engebretsen, Solveig, Aldrin, Magne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 8
container_start_page e0308978
container_title PloS one
container_volume 19
creator Engebretsen, Solveig
Aldrin, Magne
description During the COVID-19 pandemic in Norway, the testing criteria and capacity changed numerous times. In this study, we aim to assess consequences of changes in testing criteria for infectious disease surveillance. We plotted the proportion of positive PCR tests and the total number of PCR tests for different periods of the pandemic in Norway. We fitted regression models for the total number of PCR tests and the probability of positive PCR tests, with time and weekday as explanatory variables. The regression analysis focuses on the time period until 2021, i.e. before Norway started vaccination. There were clear changes in testing criteria and capacity over time. In particular, there was a marked difference in the testing regime before and after the introduction of self-testing, with a drastic increase in the proportion of positive PCR tests after the introduction of self-tests. The probability of a PCR test being positive was higher for weekends and public holidays than for Mondays-Fridays. The probability for a positive PCR test was lowest on Mondays. This implies that there were different testing criteria and/or different test-seeking behaviour on different weekdays. Though the probability of testing positive clearly changed over time, we cannot in general conclude that this occurred as a direct consequence of changes in testing policies. It is natural for the testing criteria to change during a pandemic. Though smaller changes in testing criteria do not seem to have large, abrupt consequences for the disease surveillance, larger changes like the introduction and massive use of self-tests makes the test data less useful for surveillance.
doi_str_mv 10.1371/journal.pone.0308978
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3093520742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A804938629</galeid><doaj_id>oai_doaj_org_article_c97c428228f541888ba5b56373093d0c</doaj_id><sourcerecordid>A804938629</sourcerecordid><originalsourceid>FETCH-LOGICAL-d527t-8031271bb1354e774f138e89ed4e21ccccff1befdb8a2ae335e67997a054d1d73</originalsourceid><addsrcrecordid>eNqNkl1v0zAUhiMEYh_wDxBEQkJwkeKPJLZ3g6YyoNJEJRi7xHKc49ZVGhc72di_x6EBNWgX2Be2jp_zHvv1SZJnGM0wZfjtxvW-Vc1s51qYIYq4YPxBcowFJVlJEH14sD9KTkLYIFRQXpaPkyMqcF5Swo6T7xfGgO5SZ9IOQmfbVaq97cBblRrnU9sOx9b1Ia1tABUgDb2_Ads0qtVwll6tIdVDOCrMl9eL9xkWMSv97PytunuSPDKqCfB0XE-Tbx8uruafssvlx8X8_DKrC8K6jCOKCcNVhWmRA2O5wZQDF1DnQLCOwxhcgakrrogCSgsomRBMoSKvcc3oafJir7trXJCjNUFSJGhBEMtJJBZ7onZqI3febpW_k05Z-Tvg_Eoq31ndgNSC6ZxwQrgpcsw5r1RRFSVlg1yNdNR6N1brqy3UGtrOq2YiOj1p7Vqu3I3EmJKyRMNtXo8K3v3oo_Fya4OGwVSIXu8vLmiJaERf_oPe_7yRWqn4gvhrLhbWg6g85ygX8eOJiNTsHirOGrZWx0YyNsYnCW8mCZHp4Ge3Un0IcvH1y_-zy-sp--qAXYNqunVwTR87rQ1T8Pmh1X89_tPB9Be7Tu69</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3093520742</pqid></control><display><type>article</type><title>Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Engebretsen, Solveig ; Aldrin, Magne</creator><creatorcontrib>Engebretsen, Solveig ; Aldrin, Magne</creatorcontrib><description>During the COVID-19 pandemic in Norway, the testing criteria and capacity changed numerous times. In this study, we aim to assess consequences of changes in testing criteria for infectious disease surveillance. We plotted the proportion of positive PCR tests and the total number of PCR tests for different periods of the pandemic in Norway. We fitted regression models for the total number of PCR tests and the probability of positive PCR tests, with time and weekday as explanatory variables. The regression analysis focuses on the time period until 2021, i.e. before Norway started vaccination. There were clear changes in testing criteria and capacity over time. In particular, there was a marked difference in the testing regime before and after the introduction of self-testing, with a drastic increase in the proportion of positive PCR tests after the introduction of self-tests. The probability of a PCR test being positive was higher for weekends and public holidays than for Mondays-Fridays. The probability for a positive PCR test was lowest on Mondays. This implies that there were different testing criteria and/or different test-seeking behaviour on different weekdays. Though the probability of testing positive clearly changed over time, we cannot in general conclude that this occurred as a direct consequence of changes in testing policies. It is natural for the testing criteria to change during a pandemic. Though smaller changes in testing criteria do not seem to have large, abrupt consequences for the disease surveillance, larger changes like the introduction and massive use of self-tests makes the test data less useful for surveillance.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0308978</identifier><identifier>PMID: 39146327</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Communicable diseases ; Contact tracing ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 Nucleic Acid Testing - statistics &amp; numerical data ; COVID-19 Testing - methods ; Criteria ; Disease transmission ; Health surveillance ; Hospitals ; Humans ; Infections ; Infectious diseases ; Influenza ; Laboratories ; Mathematical models ; Medicine and Health Sciences ; Norway - epidemiology ; Pandemics ; People and Places ; Public health ; Regression analysis ; Regression models ; Restrictions ; SARS-CoV-2 - genetics ; SARS-CoV-2 - isolation &amp; purification ; Self testing ; Serology ; Severe acute respiratory syndrome coronavirus 2 ; Statistical analysis ; Surveillance ; Trends ; Vaccination</subject><ispartof>PloS one, 2024-08, Vol.19 (8), p.e0308978</ispartof><rights>Copyright: © 2024 Engebretsen, Aldrin. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Engebretsen, Aldrin. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Engebretsen, Aldrin 2024 Engebretsen, Aldrin</rights><rights>2024 Engebretsen, Aldrin. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-7064-0869</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11326602/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11326602/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39146327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Engebretsen, Solveig</creatorcontrib><creatorcontrib>Aldrin, Magne</creatorcontrib><title>Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>During the COVID-19 pandemic in Norway, the testing criteria and capacity changed numerous times. In this study, we aim to assess consequences of changes in testing criteria for infectious disease surveillance. We plotted the proportion of positive PCR tests and the total number of PCR tests for different periods of the pandemic in Norway. We fitted regression models for the total number of PCR tests and the probability of positive PCR tests, with time and weekday as explanatory variables. The regression analysis focuses on the time period until 2021, i.e. before Norway started vaccination. There were clear changes in testing criteria and capacity over time. In particular, there was a marked difference in the testing regime before and after the introduction of self-testing, with a drastic increase in the proportion of positive PCR tests after the introduction of self-tests. The probability of a PCR test being positive was higher for weekends and public holidays than for Mondays-Fridays. The probability for a positive PCR test was lowest on Mondays. This implies that there were different testing criteria and/or different test-seeking behaviour on different weekdays. Though the probability of testing positive clearly changed over time, we cannot in general conclude that this occurred as a direct consequence of changes in testing policies. It is natural for the testing criteria to change during a pandemic. Though smaller changes in testing criteria do not seem to have large, abrupt consequences for the disease surveillance, larger changes like the introduction and massive use of self-tests makes the test data less useful for surveillance.</description><subject>Analysis</subject><subject>Communicable diseases</subject><subject>Contact tracing</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 Nucleic Acid Testing - statistics &amp; numerical data</subject><subject>COVID-19 Testing - methods</subject><subject>Criteria</subject><subject>Disease transmission</subject><subject>Health surveillance</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Laboratories</subject><subject>Mathematical models</subject><subject>Medicine and Health Sciences</subject><subject>Norway - epidemiology</subject><subject>Pandemics</subject><subject>People and Places</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Restrictions</subject><subject>SARS-CoV-2 - genetics</subject><subject>SARS-CoV-2 - isolation &amp; purification</subject><subject>Self testing</subject><subject>Serology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Statistical analysis</subject><subject>Surveillance</subject><subject>Trends</subject><subject>Vaccination</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1v0zAUhiMEYh_wDxBEQkJwkeKPJLZ3g6YyoNJEJRi7xHKc49ZVGhc72di_x6EBNWgX2Be2jp_zHvv1SZJnGM0wZfjtxvW-Vc1s51qYIYq4YPxBcowFJVlJEH14sD9KTkLYIFRQXpaPkyMqcF5Swo6T7xfGgO5SZ9IOQmfbVaq97cBblRrnU9sOx9b1Ia1tABUgDb2_Ads0qtVwll6tIdVDOCrMl9eL9xkWMSv97PytunuSPDKqCfB0XE-Tbx8uruafssvlx8X8_DKrC8K6jCOKCcNVhWmRA2O5wZQDF1DnQLCOwxhcgakrrogCSgsomRBMoSKvcc3oafJir7trXJCjNUFSJGhBEMtJJBZ7onZqI3febpW_k05Z-Tvg_Eoq31ndgNSC6ZxwQrgpcsw5r1RRFSVlg1yNdNR6N1brqy3UGtrOq2YiOj1p7Vqu3I3EmJKyRMNtXo8K3v3oo_Fya4OGwVSIXu8vLmiJaERf_oPe_7yRWqn4gvhrLhbWg6g85ygX8eOJiNTsHirOGrZWx0YyNsYnCW8mCZHp4Ge3Un0IcvH1y_-zy-sp--qAXYNqunVwTR87rQ1T8Pmh1X89_tPB9Be7Tu69</recordid><startdate>20240815</startdate><enddate>20240815</enddate><creator>Engebretsen, Solveig</creator><creator>Aldrin, Magne</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7064-0869</orcidid></search><sort><creationdate>20240815</creationdate><title>Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway</title><author>Engebretsen, Solveig ; Aldrin, Magne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d527t-8031271bb1354e774f138e89ed4e21ccccff1befdb8a2ae335e67997a054d1d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Communicable diseases</topic><topic>Contact tracing</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 Nucleic Acid Testing - statistics &amp; numerical data</topic><topic>COVID-19 Testing - methods</topic><topic>Criteria</topic><topic>Disease transmission</topic><topic>Health surveillance</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Laboratories</topic><topic>Mathematical models</topic><topic>Medicine and Health Sciences</topic><topic>Norway - epidemiology</topic><topic>Pandemics</topic><topic>People and Places</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Restrictions</topic><topic>SARS-CoV-2 - genetics</topic><topic>SARS-CoV-2 - isolation &amp; purification</topic><topic>Self testing</topic><topic>Serology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Statistical analysis</topic><topic>Surveillance</topic><topic>Trends</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Engebretsen, Solveig</creatorcontrib><creatorcontrib>Aldrin, Magne</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engebretsen, Solveig</au><au>Aldrin, Magne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-08-15</date><risdate>2024</risdate><volume>19</volume><issue>8</issue><spage>e0308978</spage><pages>e0308978-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>During the COVID-19 pandemic in Norway, the testing criteria and capacity changed numerous times. In this study, we aim to assess consequences of changes in testing criteria for infectious disease surveillance. We plotted the proportion of positive PCR tests and the total number of PCR tests for different periods of the pandemic in Norway. We fitted regression models for the total number of PCR tests and the probability of positive PCR tests, with time and weekday as explanatory variables. The regression analysis focuses on the time period until 2021, i.e. before Norway started vaccination. There were clear changes in testing criteria and capacity over time. In particular, there was a marked difference in the testing regime before and after the introduction of self-testing, with a drastic increase in the proportion of positive PCR tests after the introduction of self-tests. The probability of a PCR test being positive was higher for weekends and public holidays than for Mondays-Fridays. The probability for a positive PCR test was lowest on Mondays. This implies that there were different testing criteria and/or different test-seeking behaviour on different weekdays. Though the probability of testing positive clearly changed over time, we cannot in general conclude that this occurred as a direct consequence of changes in testing policies. It is natural for the testing criteria to change during a pandemic. Though smaller changes in testing criteria do not seem to have large, abrupt consequences for the disease surveillance, larger changes like the introduction and massive use of self-tests makes the test data less useful for surveillance.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39146327</pmid><doi>10.1371/journal.pone.0308978</doi><tpages>e0308978</tpages><orcidid>https://orcid.org/0000-0002-7064-0869</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2024-08, Vol.19 (8), p.e0308978
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_3093520742
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Analysis
Communicable diseases
Contact tracing
COVID-19
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 Nucleic Acid Testing - statistics & numerical data
COVID-19 Testing - methods
Criteria
Disease transmission
Health surveillance
Hospitals
Humans
Infections
Infectious diseases
Influenza
Laboratories
Mathematical models
Medicine and Health Sciences
Norway - epidemiology
Pandemics
People and Places
Public health
Regression analysis
Regression models
Restrictions
SARS-CoV-2 - genetics
SARS-CoV-2 - isolation & purification
Self testing
Serology
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Surveillance
Trends
Vaccination
title Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T04%3A04%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20testing%20criteria%20for%20infectious%20disease%20surveillance:%20The%20case%20of%20COVID-19%20in%20Norway&rft.jtitle=PloS%20one&rft.au=Engebretsen,%20Solveig&rft.date=2024-08-15&rft.volume=19&rft.issue=8&rft.spage=e0308978&rft.pages=e0308978-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0308978&rft_dat=%3Cgale_plos_%3EA804938629%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3093520742&rft_id=info:pmid/39146327&rft_galeid=A804938629&rft_doaj_id=oai_doaj_org_article_c97c428228f541888ba5b56373093d0c&rfr_iscdi=true